FDA to Begin Acne Drug Registry Next Week
- Share via
From Times Wire Reports
A registry program intended to prevent use of the acne drug Accutane by pregnant women will begin next week following an earlier delay to address concerns of doctors, federal regulators said. The iPledge system will start Wednesday, the Food and Drug Administration said. The program requires physicians, pharmacies and patients to register if they are to prescribe, sell or take the drug.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
